Loading...
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Liraglutide is a glucagon-like peptide-1 (GLP-1) analog marketed for the treatment of type 2 diabetes. Besides lowering blood glucose, liraglutide also reduces body weight. It is not fully understood how liraglutide induces weight loss or to what degree liraglutide acts directly in the brain. Here,...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215190/ https://ncbi.nlm.nih.gov/pubmed/25202980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI75276 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|